ACPU
FURX

Arrowgrass Capital Partners (US)’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-251,319
Closed -$26.7M – 406
2014
Q2 		$26.7M Buy
+251,319
New +$24.6M 0.79% 32

Arrowgrass Capital Partners (US)'s FURX Position: Q3 2014 in Review

Arrowgrass Capital Partners (US) sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 251,319 shares — an estimated $26.7M sold.

Arrowgrass Capital Partners (US) first reported a position in FURX in Q2 2014 and held it in 1 quarter. The position peaked at $26.7M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Arrowgrass Capital Partners (US) reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 251,319 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $26.7M.
  • Arrowgrass Capital Partners (US) first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $26.7M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2014, filed 14 Nov 2014.